• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然和嵌合血凝素基因对流感 A 病毒在幼仓鼠肾细胞中的复制的影响。

Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells.

机构信息

Central Veterinary Institute of Wageningen UR (CVI), P.O. Box 65, 8200 AB Lelystad, The Netherlands.

出版信息

J Biotechnol. 2012 Dec 31;162(2-3):197-201. doi: 10.1016/j.jbiotec.2012.10.005. Epub 2012 Oct 16.

DOI:10.1016/j.jbiotec.2012.10.005
PMID:23079079
Abstract

Baby hamster kidney (BHK21) cells are used to produce vaccines against various viral veterinary diseases, including rabies and foot-and-mouth-disease. Although particular influenza virus strains replicate efficiently in BHK21 cells the general use of these cells for influenza vaccine production is prohibited by the poor replication of most strains, including model strain A/PR/8/34 [H1N1] (PR8). We now show that in contrast to PR8, the related strain A/WSN/33 [H1N1] (WSN) replicates efficiently in BHK21 cells. This difference is determined by the haemagglutinin (HA) protein since reciprocal reassortant viruses with swapped HAs behave similarly with respect to growth on BHK21 cells as the parental virus from which their HA gene is derived. The ability or inability of six other influenza virus strains to grow on BHK21 cells appears to be similarly dependent on the nature of the HA gene since reassortant PR8 viruses containing the HA of these strains grow to similar titres as the parental virus from which the HA gene was derived. However, the growth to low titres of a seventh influenza strain was not due to the nature of the HA gene since a reassortant PR8 virus containing this HA grew efficiently on BHK21 cells. Taken together, these results suggest that the HA gene often primarily determines influenza replication efficiency on BHK21 cells but that in some strains other genes are also involved. High virus titres could be obtained with reassortant PR8 strains that contained a chimeric HA consisting of the HA1 domain of PR8 and the HA2 domain of WSN. HA1 contains most antigenic sites and is therefore important for vaccine efficacy. This method of producing the HA1 domain as fusion to a heterologous HA2 domain could possibly also be used for the production of HA1 domains of other viruses to enable the use of BHK21 cells as a generic platform for veterinary influenza vaccine production.

摘要

仓鼠肾细胞(BHK21)被用于生产针对各种病毒性兽医疾病的疫苗,包括狂犬病和口蹄疫。尽管某些流感病毒株在 BHK21 细胞中高效复制,但由于大多数毒株(包括模型株 A/PR/8/34 [H1N1],即 PR8)的复制效率较差,因此一般禁止使用这些细胞生产流感疫苗。我们现在表明,与 PR8 相反,相关的 A/WSN/33 [H1N1](WSN)株在 BHK21 细胞中高效复制。这种差异取决于血凝素(HA)蛋白,因为具有交换 HA 的反向重配病毒在 BHK21 细胞上的生长行为与它们的 HA 基因来源的亲本病毒相似。其他六种流感病毒株在 BHK21 细胞上生长的能力或不能力似乎也同样取决于 HA 基因的性质,因为含有这些毒株 HA 的 PR8 重配病毒的生长滴度与它们的 HA 基因来源的亲本病毒相似。然而,第七种流感病毒株的低滴度生长并不是由于 HA 基因的性质,因为含有这种 HA 的 PR8 重配病毒在 BHK21 细胞上高效生长。总之,这些结果表明,HA 基因通常主要决定流感病毒在 BHK21 细胞上的复制效率,但在某些毒株中,其他基因也参与其中。含有由 PR8 的 HA1 结构域和 WSN 的 HA2 结构域组成的嵌合 HA 的 PR8 重组株可以获得高病毒滴度。这种将 HA1 结构域融合到异源 HA2 结构域中产生 HA1 结构域的方法也可能用于生产其他病毒的 HA1 结构域,以使 BHK21 细胞成为生产兽医流感疫苗的通用平台。

相似文献

1
Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells.天然和嵌合血凝素基因对流感 A 病毒在幼仓鼠肾细胞中的复制的影响。
J Biotechnol. 2012 Dec 31;162(2-3):197-201. doi: 10.1016/j.jbiotec.2012.10.005. Epub 2012 Oct 16.
2
The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.2009年甲型H1N1流感病毒流行株的PB1片段可提高特定流感疫苗株在细胞培养物和鸡胚中的复制效率。
J Gen Virol. 2016 Mar;97(3):620-631. doi: 10.1099/jgv.0.000390. Epub 2016 Jan 7.
3
Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains.血凝素含量增加的重配 2009 年甲型 H1N1 流感病毒,其神经氨酸酶嵌合来源于 A/Puerto Rico/8/34 病毒的跨膜和茎部区域。
Vaccine. 2012 Jun 13;30(28):4144-52. doi: 10.1016/j.vaccine.2012.04.073. Epub 2012 May 1.
4
Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.H5N1 流感疫苗病毒的改进:禽源和人源内部基因片段对生产和血凝素含量的影响。
Vaccine. 2011 Jul 18;29(32):5153-62. doi: 10.1016/j.vaccine.2011.05.036. Epub 2011 May 30.
5
Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.利用具有扩展PR8骨架的嵌合HA和NA基因通过反向遗传学对甲型流感疫苗病毒进行优化。
Vaccine. 2015 Aug 20;33(35):4221-7. doi: 10.1016/j.vaccine.2015.06.112. Epub 2015 Jul 21.
6
A live bivalent influenza vaccine based on a H9N2 virus strain.基于 H9N2 病毒株的活二价流感疫苗。
Vaccine. 2010 Jan 8;28(3):673-80. doi: 10.1016/j.vaccine.2009.10.102. Epub 2009 Nov 3.
7
Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.一种基因稳定的高保真流感疫苗株的产生。
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01073-16. Print 2017 Mar 15.
8
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.利用来自禽流感病毒的全部八个基因生成减毒H5N1禽流感病毒疫苗。
Vaccine. 2007 Oct 16;25(42):7379-84. doi: 10.1016/j.vaccine.2007.08.011. Epub 2007 Aug 24.
9
Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.开发一种甲型流感主病毒,用于在合格的犬肾传代细胞(MDCK细胞)中产生高生长重配体,以生产A/安徽/1/2013(H7N9)疫苗。
PLoS One. 2016 Jul 25;11(7):e0160040. doi: 10.1371/journal.pone.0160040. eCollection 2016.
10
Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.通过表达 H1N1 血凝素 (HA) 和 M2e 融合蛋白的 DNA 疫苗实现对 H5N2 禽流感病毒的完全保护。
Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.

引用本文的文献

1
The adjuvant GLA-AF enhances human intradermal vaccine responses.佐剂 GLA-AF 增强了人体皮内疫苗的应答反应。
Sci Adv. 2018 Sep 12;4(9):eaas9930. doi: 10.1126/sciadv.aas9930. eCollection 2018 Sep.